These results showing that inhibition of Mat1a alleviates obesity and obesity-associated metabolic diseases are consistent with previous reports, which showed that disruption of other enzymes such as PEMT12 or NNMT15 involved in the methionine cycle leads to resistance to obesity. Here, MAT1A is linked to obesity due to melanocortin 4 receptor deficiency.